The NIMH multimodal treatment study for attention-deficit hyperactivity disorder: just say yes to drugs alone?

Area of Science:

• Child and Adolescent Psychiatry
• Neurodevelopmental Disorders
• Clinical Psychology

Background:

• The Multimodal Treatment Study for Children With Attention-Deficit Hyperactivity Disorder (ADHD), known as the MTA study, is a significant research endeavor.
• It addressed the need for rigorous evaluation of ADHD treatments in a large, diverse pediatric population.

Purpose of the Study:

• To describe and discuss the outcomes, merits, and limitations of the MTA study.
• To analyze design elements contributing to the MTA's landmark status in ADHD research.
• To examine potential biases in the study's design favoring pharmacological over behavioral treatments.

Main Methods:

• The MTA study involved a large, heterogeneous sample of children diagnosed with ADHD.
• It utilized state-of-the-art treatments with extensive documentation and adherence monitoring.
• Treatment fidelity was meticulously maintained throughout the lengthy study period.

Main Results:

• The study's design may have influenced outcomes, potentially favoring medication over behavioral therapy.
• Outcome assessment occurred after the intensive behavioral phase concluded but while medication was still active.
• The combined treatment condition's outcomes are discussed relative to existing ADHD literature.

Conclusions:

• The MTA study provides valuable data on ADHD treatment, despite design considerations.
• Further research is needed to fully understand the comparative effectiveness of different ADHD interventions.
• The findings inform clinical practice and future research directions for managing ADHD in children.